SLC6A4 and depressive symptom measurement: In post-stroke patients, high methylation levels of the SLC6A4 promoter have been associated with both post-stroke depression (PSD) and worsening of depressive symptoms suggesting that DNA methylation might modulate the response to stress with implications for physical function and quality of life [27].